Novacyt Stock price

Equities

ALNOV

FR0010397232

Biotechnology & Medical Research

Market Closed - Euronext Paris 11:26:18 2024-03-01 am EST 5-day change 1st Jan Change
0.5245 EUR +1.84% Intraday chart for Novacyt -7.00% -26.44%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2021 95.78M 104M Sales 2022 21.04M 22.8M Capitalization 76.79M 83.21M
Net income 2021 -9M -9.75M Net income 2022 -25M -27.09M EV / Sales 2021 1.67 x
Net cash position 2021 99.9M 108M Net cash position 2022 86.29M 93.51M EV / Sales 2022 -0.45 x
P/E ratio 2021
-26.3 x
P/E ratio 2022
-2.99 x
Employees 120
Yield 2021 *
-
Yield 2022
-
Free-Float 96.6%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.84%
1 week-7.00%
Current month+1.84%
1 month-16.61%
3 months-29.83%
6 months-39.01%
Current year-26.44%
More quotes
1 week
0.51
Extreme 0.5105
0.56
1 month
0.51
Extreme 0.5105
0.61
Current year
0.51
Extreme 0.5105
0.72
1 year
0.42
Extreme 0.42
1.00
3 years
0.42
Extreme 0.42
9.22
5 years
0.06
Extreme 0.0612
13.96
10 years
0.06
Extreme 0.0612
13.96
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 21-01-04
Director of Finance/CFO 41 17-03-31
Chief Tech/Sci/R&D Officer - 16-04-30
Members of the board TitleAgeSince
Director/Board Member 76 15-06-28
Director/Board Member 69 23-09-07
Director/Board Member 51 23-09-07
More insiders
Date Price Change Volume
24-03-01 0.5245 +1.84% 54,782
24-02-29 0.515 -2.83% 48,895
24-02-28 0.53 0.00% 87,291
24-02-27 0.53 0.00% 147,132
24-02-26 0.53 -6.03% 279,861

Real-time Euronext Paris, March 01, 2024 at 11:26 am EST

More quotes
Novacyt develops, produces, and sells in vitro and molecular diagnostic products for the microbiology, haematology and serology markets. The activity is organized around two sectors: - development of solutions and diagnostic services. The group is also developing a manufacturing activity for reagents and kits for bacterial and blood tests; - manufacture and sale of molecular screening kits (Primerdesign): for laboratories.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Novacyt - Euronext Paris
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW